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Abstract 
 
Lower resting heart rate and high autonomic vagal activity are strongly associated with 
superior exercise capacity, maintenance of which is essential for general well-being and 
healthy ageing. Recent evidence obtained in experimental studies using the latest 
advances in molecular neuroscience, combined with human exercise physiology, 
physiological modelling and genomic data suggest that the strength of cardiac vagal 
activity causally determines our ability to exercise.  
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Introduction 
 
Maintaining physical activity is essential for general well-being and healthy ageing. 
Higher exercise capacity is strongly associated with reduced risk of cardiovascular 
disease, type 2 diabetes, malignancy, osteoporosis, depression and premature death 
(14). Regular moderate exercise provides further health benefits (13, 50). It is well 
known that higher exercise capacity is strongly associated with lower resting heart rate 
and indirect measures of high cardiac vagal activity (16, 39), suggesting that the 
parasympathetic branch of the autonomic nervous system may play a key role in 
optimizing exercise performance. Despite the strong association between 
parasympathetic activity and exercise capacity, these data have long been interpreted 
as vagal activity merely being a marker for physical fitness. However, several lines of 
evidence obtained in studies of human exercise, physiological modelling, genome-wide 
association analysis and experimental animal studies now challenge this assertion. In 
this article we review these data, which collectively support the hypothesis that the 
strength of cardiac vagal activity directly determines the individual ability to exercise. 
 
Exercise and resting heart rate 
 
Resting heart rate in healthy individuals is largely determined by the restraining 
influence of the vagus nerve on cardiac pacemaker cells located within the atrial nodal 
tissue, which typically generate action potentials at an intrinsic rate of ~105 min-1(44). 
Experimental pharmacological blockade or surgical interruption of vagal cardiac 
innervation increases heart rate above this intrinsic rate (58). The resting heart rate in 
elite endurance athletes is low (values as low as 30 beats min-1 have been reported) 
and has been traditionally attributed to exceptionally high parasympathetic vagal tone 
in these select individuals (19, 76). D’Souza and colleagues, however, reported 
evidence (obtained in animal models) suggesting that the resting bradycardia 
associated with higher exercise capacity is primarily due to decreased intrinsic rate of 
cardiac pacemaker cells, established by training-induced downregulation of the 
pacemaker channel HCN4 expression (27). This view is also supported by the results of 
an earlier report which demonstrated reduced intrinsic rate of atria isolated from rats 
following exercise training (15). It remains to be determined whether the expression of 
HCN4 is modulated by autonomic activity with high vagal tone potentially restraining 
HCN4 channel expression in the nodal tissue. Indeed, there is evidence that removal of 
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cardiac vagal innervation prevents the (lowering) effect of endurance exercise training 
on resting heart rate in dogs (67). Parasympathetic vagal dysfunction induced by 
sinoaortic denervation was also reported to prevent endurance training-induced 
increases in baroreflex sensitivity and decreases in resting heart rate in rats (21). 
Although the mechanisms underlying resting bradycardia in athletes are under debate, 
the general consensus is that in humans superior exercise performance is strongly 
associated with lower resting heart rate as well as indirect measures of high cardiac 
vagal activity which will be discussed next.   
 
Assessment of vagal parasympathetic activity in humans by measuring heart 
rate recovery after exercise 
 
While resting heart rate is largely determined by the vagus nerve, additional robust 
measures of cardiac vagal activity in humans were required. The interpretation of the 
most common measure, heart rate variability, is complicated by the fact that it appears 
to be strongly dependent on resting heart rate (63) as well as the frequency and depth 
of respiration (1). Although this measure is sensitive to systemic cholinergic blockade 
(5, 72), more recent analysis provided further evidence that even nonlinear indices of 
heart rate variability are not reliable measures of cardiac vagal activity in healthy 
humans (20).  
 
An alternative, highly reproducible measure of an individual’s ability to recruit cardiac 
vagal tone is the speed of heart rate recovery (HRR) after exercise. After heart rate 
peaks during exercise, a variably steep decline occurs upon cessation of exercise, 
termed heart rate recovery (Figure 1A). HRR after exercise is mediated by rapid vagal 
reactivation (25) as demonstrated by markedly reduced rate of HRR in conditions of 
systemic muscarinic receptor blockade with atropine (43). Indicative of a causal 
relationship between the rate of HRR and exercise capacity, there is a dramatic 
absolute difference in HRR between the athletes and heart failure patients (43). 
Assessment of individual ability to recruit parasympathetic vagal tone based on HRR 
after exercise is independent of other physiological measures, including resting heart 
rate (a significant confounder in heart rate variability analysis (63)), tidal volume and 
breathing frequency (1). Yet, reduced rate of HRR after exercise correlates with other 
indirect measures of cardiac vagal tone, including heart rate variability and baroreflex 
sensitivity, if these also suggest potential impairment of autonomic function (2, 3, 83). 
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Four large clinical studies demonstrated a strong association between vagal dysfunction 
(as evident from a reduced HRR), cardiovascular morbidity and all-cause mortality (22, 
23, 45, 66). A six year follow-up study in 2,428 middle-aged men, without a history of 
heart failure or coronary revascularization, reported that impaired HRR (defined as a 
reduction of 12 beats min-1 or less during the first minute after cessation of graded 
exercise) (Figure 1A) was strongly and independently associated with mortality (22). 
HRR is a strong predictor independently of workload, the presence of myocardial 
perfusion abnormalities, and/or absolute changes in heart rate during exercise. 
Subsequent studies including more than 20,000 individuals found a similar association, 
implicating parasympathetic autonomic dysfunction as a key factor contributing to 
cardiovascular morbidity and mortality (22, 23, 45, 66) These data are also supported 
by the evidence showing strong association between mortality and baroreflex function 
(62) as well as resting heart rate (32, 89), the major autonomic determinant of which 
is cardiac vagal activity. 
 
The strong association between low resting heart rate, measures of high cardiac vagal 
activity and superior exercise capacity implies that cardiac vagal tone can be enhanced 
by exercise training. One longitudinal study performed in a group of untrained young 
individuals demonstrated that 6 weeks of aerobic exercise training reduced resting 
heart rate and increased cardiac vagal tone, as assessed by heart rate variability 
analysis (6). Studies conducted in athletes (28, 59), patients with heart failure (64, 70, 
82) and type 2 diabetes (11) have demonstrated that exercise training accelerates 
HRR, indicative of enhanced cardiac vagal function. These reports suggest that the 
vagal tone can indeed be “trained” by exercise, yet potential neurophysiological 
mechanisms (e.g. recruitment of more vagal neurons, increased excitability and 
activity of vagal neurons, facilitated transmission at the level of the ganglia) underlying 
this apparent plasticity of the autonomic nervous system remain unknown.   
 
Genetic determinants of cardiac vagal tone 
 
Although the emerging evidence suggests that cardiac vagal tone in healthy humans 
can be enhanced by exercise training, it is estimated from the results of twin studies 
that approximately 60% of HRR (and, hence, cardiac vagal activity) is determined 
genetically (65). Two recent genome-wide association studies conducted using data 
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obtained in over 50,000 participants undergoing an exercise test (United Kingdom 
Biobank) aimed to identify genes that may be associated with heart rate response to 
exercise and HRR (73, 86). There was a broad overlap between the results of two 
studies, which identified at least 16 independent genome-wide significant signals 
across 23 genetic loci. There was, however, some discordance between the results of 
two studies, which may be related to the methodological differences in the assessment 
of HRR. Nevertheless, both studies found strong associations between the resting heart 
rate, HRR and several genes expressed by the key components of the autonomic 
parasympathetic reflex signalling pathways including acetylcholinesterase and 
muscarinic M2 receptors. Other “neuronal” genes at the various loci prominently 
associated with HRR are implicated in the processes such as the control of neurite 
outgrowth, synaptic plasticity, neurotransmission and neuronal exocytosis.  
 
Autonomic control of the heart during exercise 
 
The conventional view of autonomic control of the heart during exercise has long held 
that increases in heart rate from resting baseline initially occur through (complete) 
vagal withdrawal, followed by progressive activation of the sympathetic input (75) 
(Figure 2A). However, it appears that significant cardiac vagal activity is maintained 
during exercise (Figure 2B), as suggested by the results obtained in studies using 
autonomic blockade and baroreflex stimulation during exercise (89). Indeed, the model 
of on/off thresholds for vagal/sympathetic withdrawal/activation appears to be over-
simplistic, especially if we consider that the pressor response (35) and the arterial 
baroreflex (34) contribute to the resetting of the heart rate control during exercise. The 
concept that cardiac vagal activity is maintained throughout exercise is based on the 
analysis and  modelling of the results of experimental exercise studies involving 
pharmacological blockade of autonomic limbs in healthy human volunteers. At the 
onset of exercise, vagal activity indeed decreases as a result of central command and 
resetting of the arterial baroreflex (38). However, subsequent rapid increase in venous 
return recruits/maintains cardiac vagal activity through increased baroreceptor loading 
(88). Combined withdrawal of central command and attenuation of exercise pressor 
reflex sensitivity increase cardiac output without significant changes in the arterial 
blood pressure (81). As exercise workload increases these mechanisms continually 
reset the arterial baroreflex (81). Accordingly, during exercise the heart receives 
strong vagal and sympathetic modulation at rates below 140 beats min−1 (Figure 2B). 
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At ~140 beats min-1, sympathetic and parasympathetic influences are estimated to be 
approximately equal in strength, with sympathetic activity dominating heart rate 
control at higher exercise intensities (Figure 2B). In summary, studies of human heart 
rate control suggest that the resting heart rate is by ~80% attributable to vagal 
modulation, while heart rate control during intense exercise is ~80% dependent on 
sympathetic nerve activity (89). Thus, even at high exercise loads, vagal activity 
continues to modulate cardiac function alongside with heightened activity of the 
sympathetic nervous system. It is important to emphasise that the data supporting this 
concept are circumstantial and the dynamic changes in cardiac vagal activity during 
exercise with increasing workload have never been directly assessed. Although, 
recordings of cardiac vagus in humans and animals are not feasible, changes in vagal 
activity during exercise can potentially be inferred from direct recordings of vagal 
preganglionic neuron firing during dynamic exercise in experimental animals. To the 
best of our knowledge this experiment has never been performed. Yet, there is 
evidence obtained in experimental animal studies indicating that simultaneous co-
activation of both autonomic limbs do occur in various conditions (68). 
 
Significant cardiac vagal activity which is maintained during exercise could be 
functionally important in optimizing exercise performance. If this hypothesis is correct, 
then parasympathetic vagal dysfunction would be expected to be associated with 
impaired exercise capacity. We specifically determined the relationship between HRR 
and exercise capacity in 1,293 human participants, over an age range (>65 years old) 
when vagal function declines variably (57). A graded relationship between the speed of 
HRR, resting heart rate and all prognostically relevant measures of exercise 
performance was found (Figure 1B,C). Decrements in HRR were also found to be 
strongly associated with reduced oxygen pulse (57), a robust surrogate for left 
ventricular stroke volume, suggesting that cardiac vagal activity may play an important 
role in modulation of ventricular contractility. 
 
CNS origins of cardiac vagal activity  
 
Cardiac vagal activity is generated by populations of vagal preganglionic neurons 
residing in two brainstem nuclei, – the dorsal vagal motor nucleus and the nucleus 
ambiguus. These two distinct populations of neurons have different patterns of 
discharge and provide differential control of the cardiac function (37; for a recent 
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review see [40]). Neurons of the nucleus ambiguus are rhythmic, entrained by the 
neighbouring respiratory network, and appear to exclusively control the nodal tissue 
and, therefore, the heart rate. Vagal preganglionic neurons residing in the dorsal vagal 
motor nucleus display tonic pattern of discharge which is maintained in an acute slice 
preparation (i.e. they are active in the absence of afferent input from the periphery 
and the rest of the CNS). A subpopulation of these neurons with cardiac projections is 
responsible for vagal modulation of the ventricular function (56).      
 
It is important to keep in mind that all the existing measures of cardiac vagal tone in 
humans (including HRR), assess the activity of vagal projections which innervate the 
cardiac pacemaker cells and, thus, provide chronotropic control of the heart. For the 
purpose of this consideration, we assume (but cannot be sure without experimental 
evidence) that the strength of chronotropic vagal tone (generated by the nucleus 
ambiguus) parallels the activity of vagal projections innervating the atria and the 
ventricles (generated by the dorsal vagal motor nucleus). The functional significance of 
parasympathetic ventricular innervation is considered next.  
 
Vagal innervation of the ventricles: anatomical evidence 
 
Appropriate increases in cardiac contractility are essential to support the metabolic 
demands of the exercise. If cardiac vagal activity contributes to optimizing exercise 
performance, vagal innervation of the ventricles is likely to play an important role. 
Intrinsic cardiac ganglia harbouring clusters of vagal neurons are located in the 
epicardium of the atria and the ventricular septum (31, 36, 80). There is significant 
anatomical evidence that these vagal neurons send extensive projections to all four 
chambers of the heart (8, 12, 74, 77, 90). Staining for acetylcholinesterase activity, 
immunohistochemical detection of choline acetyltransferase and other anatomical 
methods demonstrated significant cholinergic innervation of the ventricular 
myocardium in all species studied so far (24), including mice (54), rats (34, 61, 67), 
dogs (47), pigs (26, 84) and humans (47, 69). A proportion of these cardiac vagal 
fibres synapse on postganglionic sympathetic terminals (inhibiting the release of 
norepinephrine presynaptically) while the others may directly innervate the ventricular 
muscle (51) (Figure 3). 
 
Vagal innervation of the ventricles: functional evidence 
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Studies conducted in several species of experimental animals have demonstrated that 
electrical stimulation of the cervical vagus nerve causes stimulation frequency-
dependent release of acetylcholine and nitric oxide (NO) in the ventricular myocardium 
(4, 18, 33, 41, 79). Ablation of vagal neurons of the intrinsic cardiac ganglia in dogs 
abolished ventricular acetylcholinesterase activity and prevented the effect of vagal 
nerve stimulation on the ventricular electrical properties (47). Another study conducted 
in rats specifically targeted the dorsal group of the brainstem vagal preganglionic 
neurons to express an inhibitory GPCR from insects (61) and demonstrated that this 
population of neurons has a tonic effect on the electrical properties of the ventricular 
myocardium (54). Acute inhibition of the dorsal vagal motor nucleus by application of a 
specific ligand of this invertebrate receptor shortened the ventricular effective 
refractory period, lowered the ventricular tachycardia threshold, and prolonged the QT 
interval (54). The vagal influences on the ventricular electrical properties appear to be 
mediated by complex interactions between cholinergic mechanisms and these mediated 
by NO produced by the neuronal nitric oxide synthase (7, 17, 46, 54, 55). 
 
Collectively, these studies demonstrated that the vagus nerve modulates electrical 
properties of the ventricular myocardium, suggestive of direct, functionally significant 
innervation. Further studies explored whether projections of dorsal vagal preganglionic 
neurons may also modulate left ventricular contractility. That the electrical stimulation 
of the vagus nerve results in load-independent reduction of left ventricular contractility 
is well known (29, 30, 52). Whether the modulation of contractility by vagal ventricular 
innervation is tonic and functionally significant (at rest and during exercise) is less 
clear. The only human evidence is provided by the report showing that intracoronary 
atropine potentiates dobutamine‐induced inotropic responses, and this effect is absent 
in the transplanted (i.e. denervated) hearts (48). In rats under conditions of complete 
sympathetic blockade (systemic β-adrenoceptor blockade combined with spinal cord 
transection), a tonic inhibitory muscarinic influence on ventricular contractility was 
evident following systemic administration of atropine or direct pharmacological or 
genetic inhibition of the dorsal group of vagal preganglionic neurons (56). The strength 
of vagal modulation of ventricular contractility was dependent on the type of the 
anesthetic used in these studies, an important confounding factor in the experiments of 
this type, considering the high sensitivity of vagal neurons to these agents (87).  
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There is also evidence that the activity of dorsal vagal preganglionic neurons can 
effectively protect (via a muscarinic mechanism) ventricular cardiomyocytes against 
acute ischaemia/reperfusion injury (61). These neurons appear to be critically 
important for the operation of the innate reflex mechanisms which mediate inter-organ 
protection against ischaemia/reperfusion myocardial injury (through the phenomenon 
of remote ischaemic preconditioning cardioprotection) (61). These protective reflexes 
may recruit direct ventricular projections of vagal neurons as well as vagal innervation 
of the visceral organs and activation of mechanisms involving systemic actions of 
cardiotropic gut hormones, including glucagon-like peptide-1 (7, 10, 60).  
 
Exercise capacity is determined by vagal activity: molecular neuroscience data 
demonstrating causality 
 
Recent advances in molecular neuroscience allow precise control of neuronal activity 
with unprecedented specificity, spatial and temporal resolution (9). This is particularly 
important for studies of parasympathetic mechanisms, considering that the vagus is a 
mixed nerve containing motor (efferent) and sensory (afferent) fibres, making data 
obtained with the use of electrical stimulation sometimes difficult to interpret. Indeed, 
electrical stimulation of the vagus nerve at the cervical level has many shortcomings, 
not least because of the uncertainty as to which vagal fibres (afferent or efferent) are 
activated by electrical pulses, but also because of the potential recruitment of 
sympathetic axons which join the vagal trunk (78, 85). A refined approach (to avoid 
the drawbacks inherent to indiscriminate nature of nerve sectioning, systemic 
pharmacological blockade and/or electrical stimulation) to inhibit or stimulate vagal 
efferent activity would require cell-specific genetic targeting of vagal preganglionic 
neurons to express membrane proteins allowing control of their activity using light or 
specific ligands. This was achieved in rats by using viral vectors to target dorsal vagal 
preganglionic neurons to express either inhibitory GPCRs from insects (which could be 
activated by invertebrate peptides which do not have endogenous receptors in 
mammals (49)) (Figure 4A) or light-sensitive cation channels from algae (53, 61). 
 
Exercise capacity was assessed in animals transduced to express the insect inhibitory 
GPCR, light sensitive channels and respective control transgenes in neurons of the 
dorsal vagal motor nucleus (57). Experimental and control groups shared similar 
exercise capacity at baseline, however, acute silencing of the dorsal vagal 
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preganglionic neurons reversibly reduced exercise capacity by ~80% (Figure 4B). As 
chronotropic control of the heart is provided by neurons of the nucleus ambiguus 
located ventrally in the brainstem (37, 40), the effect of silencing the dorsal population 
of vagal neurons is likely to be due to impaired exercise-evoked ventricular and/or 
functional systemic hemodynamic changes, as suggested by the results of human 
studies.  
 
The same study demonstrated that optogenetic stimulation of this population of vagal 
neurons enhances cardiac contractility and prolongs exercise endurance (57). 
Mechanistic insight was provided by the evidence showing that recruitment of vagal 
activity by optogenetic stimulation of these neurons was associated with reduced 
myocardial expression of G-protein-coupled receptor kinase 2 (GRK2) and β-arrestin 2 
(57). This observation is important since these proteins are critical components of the 
intracellular machinery which controls the efficacy of β-adrenoceptor (sympathetic) 
signalling in cardiomyocytes. GRKs promote phosphorylation of the intracellular 
domains of β-adrenoceptors, recruiting arrestins to block receptor coupling to G-
proteins resulting in receptor desensitization and internalization (42) (Figure 3). 
Reduced, or inducible ablation of, cardiac GRK2 expression improves cardiac function in 
low exercise capacity states such as heart failure (71). These data obtained in 
experimental animals suggest that vagal activity may control cardiac responsiveness to 
sympathetic stimulation via modulation of expression of key negative regulators of β-
adrenoceptor-mediated signalling. 
 
Conclusions 
 
The basic science and clinical data discussed in this essay challenge the long-held 
prevailing view that the strength of cardiac vagal tone is merely a marker of physical 
fitness. The key points discussed above can be condensed as follows: 
 
 The speed of heart rate recovery after exercise provides a robust measure of 
cardiac vagal activity, which is strongly associated with exercise capacity, 
cardiovascular morbidity and all-cause mortality in humans. 
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 In health, the cardiac vagal activity is largely determined by the genetic factors, 
with strong associations identified between HRR and several genes expressed by 
the key components of autonomic reflex signalling pathways. 
 
 Cardiac vagal activity may be enhanced further even in healthy individuals through  
exercise training. 
 
 A significant level of cardiac vagal activity is maintained during exercise. 
 
 The vagus nerve provides functional innervation of the ventricles. Cardiac 
projections of a dorsal group of vagal preganglionic neurons modulate ventricular 
excitability, contractility and responsiveness of the ventricular myocardium to β-
adrenoceptor stimulation. 
 
 Inhibition of vagal neurons impairs exercise capacity, while vagal stimulation 
enhances cardiac contractility and prolongs exercise endurance (in experimental 
animals).  
 
The most logical conclusion from these lines of evidence is that the strength of cardiac 
vagal activity causally determines our ability to exercise. High cardiac vagal tone in 
elite athletes may be critically important to confer higher tolerance for intense training 
regimes, essential to achieve superior athletic performance. On the other hand, and in 
accord with this hypothesis, development of the pathology associated with progressive 
or acute parasympathetic dysfunction invariably parallels the decline in aerobic 
exercise capacity. Pharmacological or device-based neuromodulation approaches 
allowing selective recruitment of cardiac vagal activity may prove to be effective in 
enhancing the exercise capacity and promoting cardiovascular health across the 
lifespan. 
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Figure legends 
 
Figure 1| Exercise capacity is reduced in subjects with cardiac vagal dysfunction. (A) 
Cardiopulmonary exercise test protocol for measuring the speed of heart rate recovery 
(HRR) after reaching peak tolerance. (B) Resting heart rate in subjects (n=1,293), 
stratified by heart rate recovery 1 minute after cessation of cardiopulmonary exercise 
testing (HRR1). Numbers of subjects are indicated within bars. Resting heart rate is 
higher in the participants with reduced HRR. (C) In the same subjects, percentage 
population-predicted peak oxygen consumption decreases with reduced HRR. Data are 
presented as means±s.e.m. (panels B and C are adapted from Ref. 57). 
 
Figure 2| Autonomic control of the heart during exercise.  (A) Schematic representation 
of the prevailing concept of parasympathetic and sympathetic control of heart rate 
during exercise. According to this concept, vagal withdrawal is responsible for heart 
rate increases up to 100 beats min-1, followed by activation of the sympathetic input 
mediating further heart rate increases above 100 beats min-1. (B) Schematic 
representation of the parasympathetic and sympathetic contributions to the control of 
heart rate during exercise proposed by White and Raven (ref. 89). According to this 
model, significant cardiac vagal activity is maintained during exercise. In healthy 
humans, at ~140 beats min-1 sympathetic and parasympathetic influences are 
estimated to be approximately equal in strength, with sympathetic activity dominating 
heart rate control at higher exercise intensities. Yet, even at high exercise loads, vagal 
activity continues to modulate cardiac function alongside with heightened sympathetic 
activity (schematic adapted from Ref. 89). 
 
Figure 3| Schematic illustration of dual innervation and key signalling mechanisms 
underlying control of cardiac function by the autonomic nervous system. Reciprocal 
inhibition  prevents competitive effects taking place within the heart and is responsible 
for the phenomenon of a so-called “accentuated antagonism” whereby the effect of 
increased activity of one branch of the autonomic nervous system is accentuated by 
cross-inhibition of transmitter release from the nerve endings of the other branch (51). 
Mechanisms underlying modulation of G Protein-Coupled Receptor Kinase 2 (GRK2) 
and β-arrestin-2 (β-arr) expression by the vagus nerve remain to be determined. 
Cellular mechanisms downstream of cAMP and cGMP generation are not illustrated. AC 
- adenylyl cyclase; cAMP - cyclic adenosine monophosphate; M2R - muscarinic 
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acetylcholine receptor M2; sGC - soluble guanylyl cyclase; sGMP - cyclic guanosine 
monophosphate; β-AR - β-adrenoceptor. 
 
Figure 4| Exercise capacity is determined by the activity of vagal preganglionic neurons 
that reside in the dorsal vagal motor nucleus (DVMN) of the brainstem. (A) Genetic 
targeting of the DVMN vagal preganglionic neurons in rats to express an inhibitory Gi-
protein-coupled Drosophila allatostatin receptor. Left: Schematic drawings of the rat 
brain in saggital and coronal projections illustrating the anatomical location of the 
DVMN, Right: photomicrograph of a representative coronal section of the rat dorsal 
brainstem illustrating the distribution of the DVMN neurons transduced to express the 
receptor in the caudal region of the nucleus. Arrows point at ventrally projecting axons 
of the transduced vagal neurons (forming the efferent vagus nerve). XII, hypoglossal 
motor nucleus (cells are not visible); eGFP-enhanced green fluorescence protein; CC, 
central canal. Scale bar: 200 µm. (B) Summary data illustrating the effect of 
allatostatin receptor ligand (insect peptide allatostatin) administration on exercise 
capacity in rats transduced to express control transgene (left) or allatostatin receptor 
(right) by the DVMN neurons. Allatostatin binding to allatostatin receptor results in 
rapid and reversible silencing of mammalian neurons transduced to express this 
receptor (49, 61). Data are presented as individual values and means±s.e.m. 
Comparisons are made using ANOVA. (Figure adapted from Ref. 57). 
 




